Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ACSS2 | Q9NR19 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 4/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30474209 | 0.89 | TLR7 (0.48) | TP53MAPTTHRBACSS2KDM4E | |
| SCHEMBL31202954 | 0.85 | ACSS2 (0.46) | TP53MAPTTHRBACSS2KDM4E | |
| SCHEMBL26237230 | 0.85 | ACSS2 (0.46) | TP53MAPTTHRBACSS2KDM4E | |
| SCHEMBL31413166 | 0.84 | ACSS2 (0.44) | TP53MAPTTHRBACSS2KDM4E | |
| SCHEMBL27478697 | 0.84 | ACSS2 (0.43) | TP53MAPTTHRBACSS2KDM4E | |
| SCHEMBL27478696 | 0.84 | ACSS2 (0.43) | TP53MAPTTHRBACSS2KDM4E | |
| SCHEMBL24265281 | 0.82 | ACSS2 (0.49) | ACSS2KDM4EDRD2TBXA2RCNR2 | |
| SCHEMBL31413142 | 0.82 | ACSS2 (0.49) | MAPTACSS2KDM4EDRD2TBXA2R | |
| SCHEMBL25767043 | 0.81 | ACSS2 (0.46) | TP53ACSS2KDM4EDRD2TBXA2R | |
| SCHEMBL29559474 | 0.81 | TLR7 (0.48) | TP53ACSS2KDM4EDRD2TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024160271-A1 | SALT AND CRYSTAL FORM OF CYCLOALKENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏豪森药业集团有限公司 | 2024-08-08 | — | — | WO | disclosed |